_id
690dac15ccc777a4e85d095f
Ticker
AIHLF
Name
Adcock Ingram Holdings Limited
Exchange
PINK
Address
1 New Road, Midrand, South Africa, 1682
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.adcock.com
Description
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It also offers various products in the therapeutic areas, including hypertension, cholesterol, diabetes, depression, anxiety, insomnia, psychosis, epilepsy, dementia, pain, headache, inflammation, joint pain, gout, dipolar disorder, heartburn, acne, and bacterial and fungal infections. In addition, the company provides medicines for cardiovascular health, hyperlipidaemia, and metabolic syndrome; psychiatric and neurological diseases; dry skin, eczema, psoriasis, rosacea, and skin infection; and women's health comprising bacterial vaginosis, menopause, osteoporosis, and urinary. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa. Adcock Ingram Holdings Limited is a subsidiary of The Bidvest Group Limited.
Last Close
3.5
Volume
-
Current Price
3.5
Change
0
Last Updated
2025-11-08T11:31:30.185Z
Image
-
Ipo Date
-
Market Cap
624321792
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
4714234000
Cost Of Revenue
3178628000
Gross Profit
1535606000
Operating Expenses
1048278000
Operating Income
487328000
Interest Expense
57915000
Pretax Income
517375000
Net Income
389706000
Eps
2.589253798776153
Dividends Per Share
220155000
Shares Outstanding
150509000
Income Tax Expense
127669000
EBITDA
565585500
Cash
79141000
Short Term Investments
-
Receivables
2291872000
Inventories
2732504000
Total Current Assets
5120498000
Property Plant Equipment
1614153000
Total Assets
8743013000
Payables
1983792000
Short Term Debt
749316000
Long Term Debt
-
Total Liabilities
3199056000
Equity
5544012000
Depreciation
78257500
Change In Working Capital
-232991000
Cash From Operations
-201821000
Capital Expenditures
69735000
Cash From Investing
-185191000
Cash From Financing
-330920000
Net Change In Cash
-628582000
PE
10.9375
PB
0.09501810241391973
ROE
7.029313789364092
ROA
4.457342108492805
FCF
-271556000
Fcf Percent
-0.05760341977084718
Piotroski FScore
2
Health Score
54
Deep Value Investing Score
7.5
Defensive Investing Score
7
Dividend Investing Score
2
Economic Moat Investing Score
6.3
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
7.5
Net Net Investing Score
6.5
Quality Investing Score
4.5
Value Investing Score
7
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
4714234000
Quarters > 0 > income Statement > cost Of Revenue
3178628000
Quarters > 0 > income Statement > gross Profit
1535606000
Quarters > 0 > income Statement > operating Expenses
1048278000
Quarters > 0 > income Statement > operating Income
487328000
Quarters > 0 > income Statement > interest Expense
57915000
Quarters > 0 > income Statement > pretax Income
517375000
Quarters > 0 > income Statement > net Income
389706000
Quarters > 0 > income Statement > eps
2.589253798776153
Quarters > 0 > income Statement > dividends Per Share
220155000
Quarters > 0 > income Statement > shares Outstanding
150509000
Quarters > 0 > income Statement > income Tax Expense
127669000
Quarters > 0 > income Statement > EBITDA
565585500
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
79141000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2291872000
Quarters > 0 > balance Sheet > inventories
2732504000
Quarters > 0 > balance Sheet > total Current Assets
5120498000
Quarters > 0 > balance Sheet > property Plant Equipment
1614153000
Quarters > 0 > balance Sheet > total Assets
8743013000
Quarters > 0 > balance Sheet > payables
1983792000
Quarters > 0 > balance Sheet > short Term Debt
749316000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3199056000
Quarters > 0 > balance Sheet > equity
5544012000
Quarters > 0 > cash Flow > net Income
389706000
Quarters > 0 > cash Flow > depreciation
78257500
Quarters > 0 > cash Flow > change In Working Capital
-232991000
Quarters > 0 > cash Flow > cash From Operations
-201821000
Quarters > 0 > cash Flow > capital Expenditures
69735000
Quarters > 0 > cash Flow > cash From Investing
-185191000
Quarters > 0 > cash Flow > cash From Financing
-330920000
Quarters > 0 > cash Flow > net Change In Cash
-628582000
Quarters > 0 > ratios > PE
2.589253798776153
Quarters > 0 > ratios > PB
0.09501810241391973
Quarters > 0 > ratios > ROE
7.029313789364092
Quarters > 0 > ratios > ROA
4.457342108492805
Quarters > 0 > ratios > FCF
-271556000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.05760341977084718
Quarters > 0 > health Score
54
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
4902704000
Quarters > 1 > income Statement > cost Of Revenue
3328060000
Quarters > 1 > income Statement > gross Profit
1574644000
Quarters > 1 > income Statement > operating Expenses
1095567000
Quarters > 1 > income Statement > operating Income
479077000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
519325000
Quarters > 1 > income Statement > net Income
369838000
Quarters > 1 > income Statement > eps
2.4202391301331874
Quarters > 1 > income Statement > dividends Per Share
188043000
Quarters > 1 > income Statement > shares Outstanding
152810520
Quarters > 1 > income Statement > income Tax Expense
149487000
Quarters > 1 > income Statement > EBITDA
670360500
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
89417000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2048715000
Quarters > 1 > balance Sheet > inventories
2541001000
Quarters > 1 > balance Sheet > total Current Assets
4885785000
Quarters > 1 > balance Sheet > property Plant Equipment
1639030000
Quarters > 1 > balance Sheet > total Assets
8354883000
Quarters > 1 > balance Sheet > payables
1158278000
Quarters > 1 > balance Sheet > short Term Debt
42460000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2942107000
Quarters > 1 > balance Sheet > equity
5412820000
Quarters > 1 > cash Flow > net Income
369838000
Quarters > 1 > cash Flow > depreciation
200614000
Quarters > 1 > cash Flow > change In Working Capital
50264000
Quarters > 1 > cash Flow > cash From Operations
663106000
Quarters > 1 > cash Flow > capital Expenditures
54800000
Quarters > 1 > cash Flow > cash From Investing
-52403000
Quarters > 1 > cash Flow > cash From Financing
-446237000
Quarters > 1 > cash Flow > net Change In Cash
82285000
Quarters > 1 > ratios > PE
2.4202391301331874
Quarters > 1 > ratios > PB
0.09880927501745855
Quarters > 1 > ratios > ROE
6.832630680495565
Quarters > 1 > ratios > ROA
4.4266089662775645
Quarters > 1 > ratios > FCF
608306000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.12407561215198797
Quarters > 1 > health Score
66
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
2451352000
Quarters > 2 > income Statement > cost Of Revenue
1664030000
Quarters > 2 > income Statement > gross Profit
787322000
Quarters > 2 > income Statement > operating Expenses
547783500
Quarters > 2 > income Statement > operating Income
239538500
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
259662500
Quarters > 2 > income Statement > net Income
184919000
Quarters > 2 > income Statement > eps
1.2101195650665937
Quarters > 2 > income Statement > dividends Per Share
94021500
Quarters > 2 > income Statement > shares Outstanding
152810520
Quarters > 2 > income Statement > income Tax Expense
74743500
Quarters > 2 > income Statement > EBITDA
334532000
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
89417000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1944035000
Quarters > 2 > balance Sheet > inventories
2541001000
Quarters > 2 > balance Sheet > total Current Assets
4885785000
Quarters > 2 > balance Sheet > property Plant Equipment
1639030000
Quarters > 2 > balance Sheet > total Assets
8354883000
Quarters > 2 > balance Sheet > payables
1158278000
Quarters > 2 > balance Sheet > short Term Debt
42460000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2942107000
Quarters > 2 > balance Sheet > equity
5412820000
Quarters > 2 > cash Flow > net Income
184919000
Quarters > 2 > cash Flow > depreciation
100307000
Quarters > 2 > cash Flow > change In Working Capital
25132000
Quarters > 2 > cash Flow > cash From Operations
331553000
Quarters > 2 > cash Flow > capital Expenditures
27400000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-223118500
Quarters > 2 > cash Flow > net Change In Cash
82285000
Quarters > 2 > ratios > PE
1.2101195650665937
Quarters > 2 > ratios > PB
0.09880927501745855
Quarters > 2 > ratios > ROE
3.4163153402477824
Quarters > 2 > ratios > ROA
2.2133044831387823
Quarters > 2 > ratios > FCF
304153000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.12407561215198797
Quarters > 2 > health Score
62
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
4740424000
Quarters > 3 > income Statement > cost Of Revenue
3130757000
Quarters > 3 > income Statement > gross Profit
1609667000
Quarters > 3 > income Statement > operating Expenses
1023920000
Quarters > 3 > income Statement > operating Income
585747000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
605496000
Quarters > 3 > income Statement > net Income
444171000
Quarters > 3 > income Statement > eps
2.8389696717906108
Quarters > 3 > income Statement > dividends Per Share
190979000
Quarters > 3 > income Statement > shares Outstanding
156455000
Quarters > 3 > income Statement > income Tax Expense
161325000
Quarters > 3 > income Statement > EBITDA
665286000
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
107141000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2173499000
Quarters > 3 > balance Sheet > inventories
2404537000
Quarters > 3 > balance Sheet > total Current Assets
4690927000
Quarters > 3 > balance Sheet > property Plant Equipment
1689321000
Quarters > 3 > balance Sheet > total Assets
8329023000
Quarters > 3 > balance Sheet > payables
2066937000
Quarters > 3 > balance Sheet > short Term Debt
220540000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2853155000
Quarters > 3 > balance Sheet > equity
5475912000
Quarters > 3 > cash Flow > net Income
444171000
Quarters > 3 > cash Flow > depreciation
76961000
Quarters > 3 > cash Flow > change In Working Capital
-320872000
Quarters > 3 > cash Flow > cash From Operations
280722000
Quarters > 3 > cash Flow > capital Expenditures
72941000
Quarters > 3 > cash Flow > cash From Investing
-72734000
Quarters > 3 > cash Flow > cash From Financing
-364194000
Quarters > 3 > cash Flow > net Change In Cash
-78526000
Quarters > 3 > ratios > PE
2.8389696717906108
Quarters > 3 > ratios > PB
0.10000023740337684
Quarters > 3 > ratios > ROE
8.111361176001369
Quarters > 3 > ratios > ROA
5.3328103428217215
Quarters > 3 > ratios > FCF
207781000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.043831733195174104
Quarters > 3 > health Score
59
Valuation > metrics > PE
10.9375
Valuation > metrics > PB
0.09501810241391973
Valuation > final Score
100
Valuation > verdict
45.2% Undervalued
Profitability > metrics > ROE
7.029313789364092
Profitability > metrics > ROA
7.610705052516377
Profitability > metrics > Net Margin
0.08266581590985937
Profitability > final Score
49
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5770290540496665
Risk > metrics > Interest Coverage
8.414538547871881
Risk > final Score
82
Risk > verdict
Low
Liquidity > metrics > Current Ratio
1.873507376949612
Liquidity > metrics > Quick Ratio
0.8737283707778837
Liquidity > final Score
91
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
48
Prev Profitabilities > 1
30
Prev Profitabilities > 2
59
Prev Risks > 0
61
Prev Risks > 1
61
Prev Risks > 2
87
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:21:17.864Z
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It also offers various products in the therapeutic areas, including hypertension, cholesterol, diabetes, depression, anxiety, insomnia, psychosis, epilepsy, dementia, pain, headache, inflammation, joint pain, gout, dipolar disorder, heartburn, acne, and bacterial and fungal infections. In addition, the company provides medicines for cardiovascular health, hyperlipidaemia, and metabolic syndrome; psychiatric and neurological diseases; dry skin, eczema, psoriasis, rosacea, and skin infection; and women's health comprising bacterial vaginosis, menopause, osteoporosis, and urinary. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa. Adcock Ingram Holdings Limited is a subsidiary of The Bidvest Group Limited.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-12-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Adcock Ingram Holdings Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.